Welcome to ASTRO's 47th Annual Meeting streaming presentations page. To view the presentations you must have RealPlayer installed. If you do not, click here to download it. In addition, if you are using Internet Explorer you may need to change your personal settings to allow pop-up windows and blocked active content. Thank you.


Welcome Address
Laurie E. Gaspar, M.D., University of Colorado Health Sciences Center, Aurora, CO

PRESIDENTIAL COURSE - ”Expanding the Horizons of Radiation Therapy"

Prabhakar Tripuraneni, M.D., F.A.C.R., Scripps Clinic, La Jolla, CA

Harnessing Technological Innovation and Biological Advances to Improve the Therapeutic Ratio
Steven A. Leibel, M.D., Stanford Cancer Center, Stanford, CA

SESSION I: Image-guided Radiotherapy (IGRT)
Moderator: Najeeb Mohideen, M.D.

Image Guidance Systems in the Treatment Room: The Indications, Applications and Impact on Clinical Practice
David A. Jaffray, Ph.D., Princess Margaret Hospital, Toronto ON, Canada

Optical Tracking in Radiotherapy
Sanford Lee Meeks, Ph.D., M.D. Anderson Cancer Center, Orlando, FL

4D CT Imaging in Radiotherapy: Acquisition and Applications
Paul Keall, Ph.D., Virginia Commonwealth University, Richmond, VA

Image Guided Radiotherapy for Lung Cancer
Suresh Senan, M.B., B.S., Ph.D., VU University Medical Centre, Amsterdam, Netherlands

Stereotactic Body Radiotherapy

US Experience
Robert D. Timmerman, M.D., University of Texas Southwestern, Dallas, TX

Japanese Experience
Hiroki Shirato, M.D., Hokkaido University School of Medicine, Sapparo, Japan

IGRT for Prostate Cancer
Patrick A. Kupelian, M.D., M.D. Anderson Cancer Center, Orlando, FL

Future Directions in CT-Based IGRT

Cone Beam Technology
Marcel van Herk, Ph.D., Netherlands Cancer Institute, Amsterdam, Netherlands
Jean Pouliot, Ph.D., University of California, San Francisco, CA

Wolfgang Tome, Ph.D., University of Wisconsin, Madison, WI

SESSION II: Biological Modifiers of Radiotherapy
Moderator: Carolyn I. Sartor, M.D.

Why should the Practicing Radiation Oncologist Care about Biologics?
C. Norman Coleman, M.D., NIH/NCI, Bethesda, MD

Biologics - Nuts and Bolts and Strategies for Application in Your Clinic
Carolyn I. Sartor, M.D., UNC-CH School of Medicine, Chapel Hill, NC<

SESSION III: Systemic Targeted Radionuclide Therapy (STaRT)
Moderator: Paul E. Wallner, D.O.

From Bench to Clinic of Radiolabeled Antibodies
Andrew A. Raubitschek, M.D., City of Hope, Duarte, CA

STaRT Nuts and Bolts and Strategies for Application in Your Practice
Paul E. Wallner, D.O., 21 Century Oncology, Ft. Meyers, FL

SESSION IV: Protons Versus Photons Fest
Moderator: Anthony L. Zietman, M.D.

Physics of Protons
Alfred R. Smith, Ph.D., M.D. Anderson Cancer Center, Houston, TX

Clinical Use of Protons
Thomas F. DeLaney, M.D., Massachusetts General Hospital, Boston, MA

Prostate Cancer
Moderator: Anthony L. Zietman, M.D., Massachusetts General Hospital, Boston, MA

Carl J. Rossi, Jr., M.D., Loma Linda University Medical Center, Loma Linda, CA

Alan Pollack, M.D., Ph.D., Fox Chase Cancer Center, Philadelphia, PA

Louis Potters, M.D., South Nassau Communities Hospital, Oceanside, NY

Why Did we Choose to go With Protons?

University of Florida Proton Therapy and Research Center
Nancy P. Mendenhall, M.D., University of Florida/Shands Cancer Center, Gainesville, FL

The Compelling Path to Protons
James D. Cox, M.D., M.D. Anderson Cancer Center, Houston, TX



ASTRO/American Cancer Society Lecture
Paul E. Farmer, M.D., Ph.D., Medical Anthropologist and Physician, Harvard Medical School and
Brigham and Women's, Hospital, Boston, MA


Looking Beyond Our Horizons: Expansion or Extinction?
Prabhakar Tripuraneni, M.D., F.A.C.R., Scripps Clinic, La Jolla, CA

Moderators: Prabhakar Tripuraneni, M.D. and Stephen M. Hahn, M.D.

Phase III Randomized Study of Adjuvant Radiation Therapy Versus Observation in Patients with
Pathologic T3 Prostate Cancer (SWOG 8794)

Gregory P. Swanson, M.D.
Discussant: Richard Valicenti, M.D.

Comparison of 30 Gy versus 20 Gy Involved Field Radiotherapy After Two versus Four Cycles ABVD
in Early Stage Hodgkin's Lymphoma: Interim Analysis of the German Hodgkin Study Group Trial HD10

Rolf P. Mueller, M.D., University of Cologne, Cologne, Germany
Discussant: Andrea Ng, M.D., M.P.H.

Lumpectomy plus Tamoxifen or Arimidex With or Without whole Breast Irradiation in Women with
Favorable Early Breast Cancer

Richard Poetter, M.D.
Discussant: Kevin S. Hughes, M.D.

Preoperative Chemoradiotherapy (CT-RT) Improves Local Control in T3-4 Rectal Cancers: Results of
the FFCD 9203 Randomized Trial

Pascale Romestaing, M.D.
Discussant: A. William Blackstock


Moderators: Prabhakar Tripuraneni, M.D. and Stephen M. Hahn, M.D.

Adaptive Planning and Delivery to Account for Anatomical Changes Induced by Radiation Therapy of Head and Neck Cancer
Michael B. Sharpe, Ph.D.
Discussant: Suresh Senan, M.B. B.S., Ph.D.

Objective vs. Subjective Assessment of Single Photon Emission Computed Tomography (SPECT) Cardiac Perfusion Scans to Assess for Radiation Therapy (RT)-Induced Cardiac Injury
Robert G. Prosnitz, M.D.
Discussant: Jay R. Harris, M.D.

The Influence of Intrafraction Movement on Margins for Prostate Radiotherapy
Dale W. Litzenberg, Ph.D.
Discussant: Charles A. Enke, M.D.


ASTRO Gold Medal Awards
C. Norman Coleman, M.D.,Tribute by Theodore Phillips, M.D.

Allen S. Lichter, M.D., Tribute by Steven A. Leibel, M.D.

Honorary Member
Frank J. Mahoney, Ph.D, Tribute by Paul E. Wallner, D.O.



Angiogensis and the Radiation Response
Judah Folkman, M.D., Andrus Professor of Pediatric Surgery and Professor of Cell Biology, Children's Hospital and Harvard Medical School, Boston, MA

Click here to download the free RealPlayer.

Copyright ©2005 American Society for Theraputic Radiology and Oncology. All rights reserved.